Challenges of automation of cell based assays presentation

John White of GSK on behalf of The BioPhorum Bioassay workstream, consisting of 34 global companies from the biopharmaceutical industry,  presents the results of discussion and benchmarking survey on the automation of cell-based potency assays at the Well Characterized Biologics and Biological Assays conference (October 2021). The survey and talks focus on a number of topics including; handling of cells, transitioning from manual to automated assays and validation approaches when assays are both manual and automated.

 

This document is reserved for the use of BioPhorum members only.

I don't have access to this document

Make a selection below and submit your request. We will get back to you ASAP.

My company would like to become a member

If you're not sure if your company is a member of this Phorum, or if you would like to enquire on behalf of your company about becoming a member, please see our membership page.

Preview